To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
Value-based contracts often require significant time to reach final negotiation and implementation. Disconnect, misalignment, and lack of a common framework for value-based purchasing agreements has exacerbated these challenges. This lexicon provides a unified language for discussing and designing value-based contracts across payers, provider systems, and manufacturers.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.